Gene/Event |
Cancer Type |
Patient |
Variant |
Mutation Level |
FBLN2 |
Breast Cancer | p131_case5 |
p.R1180C |
Trunk mutation |
FBLN2 |
Colorectal Cancer | p001_PCRC05 |
Chr3:13655643:C>T |
Branch mutation |
FBLN2 |
Colorectal Cancer | p014_CRC4 |
p.A571T |
Trunk mutation |
FBLN2 |
Colorectal Cancer | p034_MSU1 |
Chr3:13679125:G>A |
Trunk mutation |
FBLN2 |
Colorectal Cancer | p034_MSU2 |
Chr3:13660486:G>A |
Trunk mutation |
FBLN2 |
Colorectal Cancer | p034_MSU2 |
Chr3:13663411:C>T |
Private mutation |
FBLN2 |
Esophageal Squamous Cell Carcinoma | p128_P02 |
Chr3:13669371:C>T |
Private mutation |
FBLN2 |
Esophageal Squamous Cell Carcinoma | p128_P09 |
Chr3:13611955:A>G |
Private mutation |
FBLN2 |
Gastric Adenocarcinoma | p011_MSI-H1 |
p.A25A |
Trunk mutation |
FBLN2 |
Gastric Carcinoma | p106_GC15 |
p.R527R |
Trunk mutation |
FBLN2 |
Glioblastoma | p070_HGG2 |
Chr3:13679191:G>A |
Trunk mutation |
FBLN2 |
Glioma | p168_P01 |
p.P401L |
Private mutation |
FBLN2 |
Hepato-Cholangiocarcinoma | p078_p2 |
p.Q837L |
Trunk mutation |
FBLN2 |
Hepatocellular Carcinoma | p151_HCC5647 |
Chr3:13669431:T>A |
Trunk mutation |
FBLN2 |
Hepatocellular Carcinoma | p151_HCC5647 |
Chr3:13677943:A>T |
Trunk mutation |
FBLN2 |
Hepatocellular Carcinoma | p157_p5 |
p.G523V |
Trunk mutation |
FBLN2 |
Lung Adenocarcinoma | p017_270 |
Chr3:13671384:C>T |
Trunk mutation |
FBLN2 |
Ovarian Cancer | p144_AOCS139 |
p.A1016D |
Private mutation |
FBLN2 |
Ovarian Cancer | p153_RJOC08 |
p.C479Y |
Private mutation |
FBLN2 |
Prostate Cancer | p105_1029 |
p.R1105C |
Private mutation |
FBLN2 |
Prostate Cancer | p164_P1 |
p.T854A |
Branch mutation |
FBLN2 |
Prostate Cancer | p164_P2 |
p.T854A |
Trunk mutation |
FBLN2 |
Prostate Cancer | p164_P2 |
p.A10V |
Branch mutation |
FBLN2 |
Prostate Cancer | p164_P2 |
p.S361G |
Private mutation |
FBLN2 |
Renal Cell Carcinoma | p073_RCC5 |
Chr3:13612512:T>G |
Trunk mutation |
FBLN2 |
Salivary Adenoid Cystic Carcinoma | p077_p2 |
Chr3:13609742:C>T |
Trunk mutation |